Lilly Pops After Weight-Loss Drug Succeeds In Sleep Apnea Study

stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events in people with obesity. The results bolster Lilly's argument that lowering a person's body weight could improve sleep apnea, a condition in which breathing while sleep becomes more…#lilly #elililly #davidsong #tema #hrts #cpap #resmed #leerinkpartners #davidrisinger #temasong
Source: Reuters: Health - Category: Consumer Health News Source Type: news